Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Baxter International Inc (BAX) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance

Baxter International IncTrade
NEOS S&P 500 High Income ETFTrade

Price performance (Past 24H)

Key statistics

Baxter International Inc vs NEOS S&P 500 High Income ETF — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while NEOS S&P 500 High Income ETF trades at $54.25. The key difference: Baxter International Inc pays a 0.14% dividend while NEOS S&P 500 High Income ETF pays none. Which is the better fit depends on your goals.

BAXSPYI
Market Cap
$14.27B
Sector
HealthIncome / Options Overlay
52-Week High
$28.35$54.19
52-Week Low
$15.80$47.98
Enterprise Value
$21.79B
Dividend Yield
0.14%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Baxter International Inc

Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.

The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.

NEOS S&P 500 High Income ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Baxter International Inc

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.

Read more on BAX

About NEOS S&P 500 High Income ETF

SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.

Read more on SPYI